Categories
Windlas Biotech Limited — Updates, 21-05-2026: Press Release
21-05-2026 · 05:34 pm
Windlas Biotech achieved record FY26 revenue of Rs 904 Cr, up 19% YoY, fueled by 20% CDMO growth. Adjusted PAT rose 31% to Rs 83 Cr. With Rs 251 Cr net liquidity and debt-free status, the company saw strong cash generation and Plant-6 nearing commercialization.
No comments yet. Be the first to comment!